“…However, the detailed cellular and molecular events that drive this process still need to be clearly dissected. The field has taken some forward steps with the increase availability of tools, such as antibodies and cDNAs (Klein et al, 1990; Bugra et al, 1992; Negishi et al, 1992; Mitashov et al, 1995; Saito et al, 1994; Chiba et al, 1997; Cheon et al, 1998; Kaneko et al, 1999, 2001; Sakakibara et al, 2002). Further steps need to be taken to bring this field into the molecular age, including the use of new technology, such as morpholinos and RNAi to create knockdown animals (Heasman, 2002; Zhou et al, 2002), the use of viral vectors (Burns et al, 1994; Roy et al, 2000; Kumar et al, 2000) to bypass the production of transgenic animals (very difficult to produce in urodeles) by creating “on site transgenics,” or by the use of tissue/organ cultures that could be manipulated with the addition of key factors or genes (Ikegami et al, 2002).…”